Background: Gray matter (GM) alterations in Parkinson’s disease (PD) patients with rapid eye movement sleep behavior disorder (RBD) have been demonstrated in many neuroimaging studies using voxel-based morphometry (VBM). However, the inconsistent findings between studies cannot be applied to clinical practice as a neuroimaging biomarker. We performed a meta-analysis of VBM studies at a whole-brain […]

Purpose: Individuals with presbycusis often show deficits in cognitive function, however, the exact neurophysiological mechanisms are not well understood. This study explored the alterations in intra- and inter-network functional connectivity (FC) of multiple networks in presbycusis patients, and further correlated FC with cognitive assessment scores to assess their ability to predict cognitive impairment.Methods: Resting-state functional […]

Levodopa (L-DOPA) treatment is the main gold-standard therapy for Parkinson disease (PD). Besides good antiparkinsonian effects, prolonged use of this drug is associated to the development of involuntary movements known as L-DOPA-induced dyskinesia (LID). L-DOPA-induced dyskinesia is linked to a sensitization of dopamine (DA) D1 receptors located on spiny projection neurons (SPNs) of the dorsal […]